Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH

WILEY-LISS

1. AHRQ HHS [HS-10389] Funding Source: Medline
2. NIAMS NIH HHS [T32-AR-47512-03, K24-AR-052361-01] Funding Source: Medline
3. PHS HHS [223-02-1420] Funding Source: Medline